This study aims to investigate the role of clinical pharmacist in the development of a pharmaceutical care program for patients with Acute coronary syndrome tailored to their specific learning needs and their cultural context, and to verify the program's effects on physiological factors and recurrent symptoms or cardiac events.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
40
Ain Shams University
Cairo, Egypt
Change in the level of patient education about disease, drugs and lifestyle modification using coronary artery disease education questionnaire (CADE-Q)
at baseline and after three months
Time frame: three months
Change in the number of solved drug-related problems
assessment of drug-related problems at baseline and solving them during three months
Time frame: three months
Assessment of medications adherence: (Eight-item Morisky adherence questionnaire).
at baseline and after three months
Time frame: three months
Assessment of quality of life: (36-items self-care Health survey (SF-36)).
at baseline and after three months
Time frame: three months
Assessment of smoker's dependence on cigarette smoking: (using the Fagerstrom Test for Nicotine Dependence).
at baseline and after three months
Time frame: three months
Change in heart rate [HR] (Bpm).
at baseline and after three months
Time frame: three months
Change in Lipid profile : total cholesterol (mg/dl), triglycerides(mg/dl), and low density lipoprotein cholesterol(mg/dl), high density lipoprotein (mg/dl)
at baseline and after three months
Time frame: three months
Change in levels of fasting blood glucose (mg/dl)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
at baseline and after three months
Time frame: three months
Change in systolic and diastolic blood pressure [BP] (mmHg).
at baseline and after three months
Time frame: three months